Gilead Sciences

-$1.73 (-2.56%) Today
+$0.03 (+0.05%) As of 11:21 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GILD and other ETFs, options, and stocks.

About GILD

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.

CEO
Daniel P. O'Day
Employees
13,600
Headquarters
Foster City, California
Founded
1987

GILD Key Statistics

Market Cap
82.63B
Price-Earnings Ratio
16.51
Dividend Yield
4.15
Average Volume
6.07M
High Today
$67.59
Low Today
$65.78
Open Price
$67.52
Volume
7.52M
52 Week High
$73.34
52 Week Low
$56.56

GILD News

MarketWatchOct 15

Gilead's Sacituzumab Govitecan Gets Positive CHMP Opinion in Breast Cancer

By Michael Dabaie Gilead Sciences Inc. said the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion for
Simply Wall StOct 14

What Kind Of Shareholders Own Gilead Sciences, Inc.?

A look at the shareholders of Gilead Sciences, Inc. (NASDAQ:GILD) can tell us which group is most powerful. Large companies usually have institutions as shareho

GILD Earnings

$0.00
$0.73
$1.46
$2.19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Oct 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure